National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

rosiglitazone (roh-sig-LIH-tuh-zone)

 The active ingredient in a drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment of some types of cancer. Rosiglitazone stops cells from growing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of thiazolidinedione and a type of antiangiogenesis agent.



Previous Definitions:Roman chamomile, romidepsin, romiplostim, ropivacaine, ropivacaine hydrochloride
Next Definitions:rosiglitazone maleate, RPI.4610, RPR 109881A, RSR13, RSV

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov